Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
Abemaciclib and Letrozole to Treat Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib + Pembrolizumab In Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6
- Status
- TERMINATED
- Phase
- EARLY_PHASE1